17 Living with and beyond cancer
• To introduce the concept of survivorship
• To understand the transition from acute care and treatment into follow up
• To understand the potential long-term consequences of cancer and its treatment
• To appreciate the supportive strategies required by those living with and beyond cancer to live a healthy and active life.
Introduction
The general public frequently associate a diagnosis of cancer with death. In reality, the situation is often very different. Health policy in the UK has focused on prompt diagnosis and national equity of evidence-based treatment, resulting in earlier cancer detection and wider availability of effective cancer treatments, thus reducing the mortality rates (DH 1995, 1998, 2000, 2004). Consequently, the UK is experiencing increasing numbers of individuals surviving a cancer diagnosis and treatment (5-year survival = 56% for women, 43% for men; 10-year survival = 52% women and 39% men (Office for National Statistics (ONS) 2007)).
There are currently 1.6 million people living in England with a cancer diagnosis. This number is predicted to rise by over 3% per year (ONS 2008). By 2030, it is estimated that over 3 million people will be living with or beyond a cancer diagnosis in England (DH et al 2010). This increase has significant implications for individual patients and for the health service in terms of how this group of patients can best be managed and supported in the longer term.
Cancer is increasingly becoming a chronic disease, characterised by intense treatment, remissions and long periods of outpatient follow up (Dennison & Shute 2000). Once active treatment is complete and patients return home, contact with healthcare professionals diminishes and family members are increasingly required to contribute to the patients’ physical and psychological management. This demanding role often results in physical and emotional repercussions for the lay carer (Badr & Carmack Taylor 2006).
Although many cancer survivors return to previous employment and lifestyles, attempting to put the cancer diagnosis and cancer treatment behind them, there is a higher incidence of chronic illness and disability in cancer survivors compared with those without a cancer diagnosis (Sugimura & Yang 2006). Patients may experience physical and psychosocial problems that result from the disease itself or its treatment. Some problems have a time limit, others persist, while others may not appear until months or years later (Cooley 2000). Currently, the long-term effects of cancer treatment are not systematically identified or recorded; there are few diagnostic or integrated care pathways linking changes in health resulting from the consequences of cancer treatments and few specialist services are available for those with ongoing complex needs.
The concept of survivorship
So when does someone become a ‘cancer survivor’? Traditionally we have thought of survivorship, in terms of the medical end point of treatment and when the patient is discharged from hospital follow-up care, at either 1 or 5 years. However, in reality, these time points are irrelevant to the patient and do not reflect the ongoing consequences of the disease and treatment. The National Coalition for Cancer Survivorship (1986) considers that an individual is a cancer survivor from the time of diagnosis, through the balance of his or her life. Family members, friends, and caregivers are also impacted by the survivorship experience and are therefore included in this definition. This definition highlights that it isn’t just the patient who is affected by the consequences of cancer and its treatment, and that these consequences commence from the time of symptom presentation or diagnosis and continue throughout the duration of an individual’s life. Mullan (1985) proposes that survivorship is transitional, rather than a series of distinct stages, and there are three phases of survival: acute (during the diagnostic phase); extended (when treatment is over); and permanent survival. To date, there has been a lack of attention given to the extended phase of post-treatment and very little exploration of what are the best strategies to support these patients through the transition of these phases.
Much of the literature and research has been completed in the USA and is referred to as ‘survivorship’. Patients in the UK tend to dislike this label, as it implies victim status. For this reason, the phrase ‘living with and beyond cancer’ has be adopted (Macmillan Cancer Support 2008a, DH et al 2010).
The transition from acute care and treatment into follow up
Patients often experience negative emotions towards the often abrupt withdrawal of intensive support (from healthcare professionals, family and friends) once treatment is complete. This is often associated with ambivalence to discontinuation of treatment, signifying the loss of a security blanket (Moore 2011). Paradoxically, the post-treatment period is idealised by family and friends who attempt to persuade the individual they are lucky and encourage them to ‘get back to normal’. Although patients convey a need to resume life, there is recognition and frustration that life before cancer cannot be resumed and patients and carers may feel confused when feelings of anxiety and depression linger after the patient has been told treatment has been successful. Rather than ‘getting back to normal’, patients need to adjust to a new situation and, although the cancer may have physically been removed, the effects of cancer and treatment as well as feelings accompanying the experience may not leave them.
Once treatment has been completed, patients will be seen in an outpatient setting for a ‘follow-up’ appointment. The purpose of this is to review the patient’s physical health and assess the response to treatment. However, the value and purpose of formal follow-up clinic appointments in relation to the management of cancer patients has been debated over the past few decades. Rather than a means of support or providing information, traditionally the emphasis of follow-up appointments has been focused on record keeping, disease surveillance, detection and treatment of recurrence (Torjesen 2010). However, the effectiveness and efficiency of follow-up to detect recurrent cancer has been disputed (Alberts 2007).
Alongside this, the health system is under enormous pressure to ensure people with a suspected cancer are seen by a specialist within a 2-week target of being referred by their GP and patients diagnosed with cancer are treated within 31 days from diagnosis (DH 2004). This has increased the pressure on outpatient follow-up clinics and the appointment time between completing acute treatment and follow up for patients with cancer has lengthened. This affects the support and access to information and reduces the opportunities for patients and carers to ask questions.
Patients report mixed feelings regarding follow-up appointments: it may provide feelings of security and reassurance; reduce physical distress and anxiety; and is a way of providing information regarding prognosis and recovery. Conversely, many patients experience acute anxiety preceding follow-up appointments as they are confronted with fear of recurrence and a reminder of their experience. Often the focus of follow up is on the physical symptoms, largely ignoring psychosocial aspects (Torjesen 2010). It is also argued that due to regimented scheduling, the timing of follow-up appointments rarely coincides with patients experiencing anxiety and the need for questions to be answered. Patients often feel unable to contact healthcare professionals for information in between appointments or don’t know who to ask for help.
Follow-up appointments are set in busy hospital clinics and are of a short duration, limiting the time available for patients to express concerns or seek information regarding rehabilitation and recurrence, and therefore are unlikely to provide the level of reassurance and support that patients need. Follow up could be initiated by the patient and should be driven by an assessment of the patient’s need for support, rather than stipulated by protocol (Torjesen 2010). Patients may benefit from a ‘debrief’ by the treatment team at 1 and 6 months after the completion of treatment to discuss and clarify what happened (Johansson et al 1992). Telephone follow up has been shown to be acceptable and more convenient to patients. Phone calls are prearranged and made by a nurse specialist to find out about patients’ progress and answer any questions they may have (Cox & Wilson 2003). These options are currently being explored by the National Cancer Survivorship Initiative task force (DH et al 2010). This is discussed later.
The potential long-term consequences of cancer and its treatment
Physical impact
Historically, the long-term consequences of cancer and its treatment have been difficult to research, due to the high mortality rates associated with the disease. The extent of physical impact will depend on the type of cancer; types and combination of treatments given; pretreatment performance status; presence of co-morbidity; and prompt recognition and intervention of toxicities. These will influence the long-term health and quality of life among survivors. Although the severity of symptoms may diminish over time, debilitating symptoms such as pain, fatigue, poor appetite, weight loss, insomnia, loss of fertility, hormone alteration and impaired sexual functioning can persist for many months/years, associated with a poor quality of life (Brant et al 2011). For example, the extent of surgery will vary depending on whether the patient is undergoing curative treatment and whether they are physically well enough to undergo the procedure. The more extensive the surgery, the more physically compromised a patient will be postoperatively.
The Macmillan health and wellbeing survey (Macmillan Cancer Support 2008b) identified that 78% of patients living beyond cancer experience at least one physical health problem within 12 months of completing treatment and 71% of patients who finished treatment 10 years ago continue to experience physical health problems. To give a specific illustration of this, 21% of patients spend most of the day in bed due to respiratory problems 12 months following the surgical removal of lung cancer (Sarna et al 2004); 30% of patients with lung cancer express significant chronic pain 4 years postoperatively (Karmaker & Ho 2004) and almost all patients report debilitating shortness of breath 10 years after surgery affecting their quality of life and requiring long-term adaptation (Maliski et al 2003).
Psychosocial impact
Unsurprisingly, the burden of physical symptoms experienced by patients recovering from cancer treatments has a significant long,term impact on psychosocial wellbeing, as well as affecting the emotional wellbeing of spouses (Sarna & McCorkle 1996). The majority of cancer patients experience uncertainty, anxiety, apprehension, loss of confidence, loss of normality, lower sexual activity and have unrealised employment and retirement plans due to the physical limitations of treatment and disease. Yet healthcare professionals generally underestimate psychological symptoms. For example, 66% of patients with lung cancer report anxiety as a significant problem, yet healthcare professionals estimate only 23% of patients with lung cancer experience anxiety; 49% of patients report depression but consultants do not recognise this at all (Krishnasamy et al 2001). Many patients meet and become friends with other patients. This can be a great source of support, however it may be quite distressing if another patient dies. As well as heightening the sense of their own mortality, they may feel a sense of guilt: ‘Why wasn’t it me?’
Uncertainty is a significant issue for the majority of patients and their family members as there are many questions that cannot be answered: What will the outcome of treatment be? Has the cancer gone completely? What will the long-term outcome be? The fear of recurrence is an emotional burden to a greater or lesser extent for the majority of patients and carers (Llewellyn et al 2008). Often referred to as the ‘Sword of Damocles’ which hangs over the individual and family for the rest of the person’s life, the fear of recurrence creates anxiety and uncertainty for the future, as well as interfering with normal daily living. This fear may diminish over time or may continue to be a long-term problem (Ronson & Body 2002).
Conversely, a cancer diagnosis may trigger a greater appreciation of life (Wyatt et al 1993). Once treatment has finished, some individuals take stock and reprioritise their plans and life objectives, making more time for important activities. There may be changes in lifestyle behaviours, such as eating habits and other healthy activities.
Economic and employment impact
Depending on the nature of employment and the type/severity of cancer and treatment-related side effects, many patients attempt to continue to try to retain their role and routine, as well as maintain an income, while undergoing treatment. Many people do not have employment sick pay or leave schemes, so if they do not work they do not get paid. Many continue to work as they fear that they will lose their job, due to the numerous absences to attend hospital appointments and receive treatments, and time off to recover from the consequences of toxicities. Being a patient can also be very costly with multiple prescriptions, car parking, etc. Unsurprisingly, 92% of people affected by cancer suffer loss of income and/or higher costs. Patients under 55 years old suffer an average fall in income of 50%, causing significant hardship (RDSi research commissioned by Macmillan Cancer Relief 2006).
Even if patients return to work after treatment, they may feel trapped in their job or feel that their options for promotion are limited. They may not feel able to move to a new employer, in case of risking loss of sick pay/leave. It may be more difficult to secure a new position if an occupational health screen is required. They may face the dilemma of whether they should tell their potential employer at all about their diagnosis. In 2005, the Disability Discrimination Act was extended to apply to cancer patients from the point of diagnosis. The Act gives individuals who have/had a cancer diagnosis protection from discrimination in employment and education. However, only one in five employers are aware that cancer is covered by the Act. This makes patients very vulnerable to losing their jobs and they themselves often do not realise that they are protected by the Act (Simm et al 2007). The Equality Act (2010) replaces current discrimination laws, including the Disability Discrimination Act (1995), bringing them all together under one piece of legislation. The Act aims to make discrimination legislation more consistent, clearer and easier to follow.
The supportive strategies required by those living with and beyond cancer to live a healthy and active life
More challenging is how to manage the unanswerable questions such as ‘Am I cured?’ and ‘Will it come back?’ Llewellyn et al (2008) suggest that it is impossible to eliminate uncertainty and fear of recurrence, but by developing patients’ cancer knowledge, they can manage using emotional and problem-based coping strategies. This suggests the need to evaluate the current focus of health care and a shift in attitudes and approaches is required to support individuals beyond cancer treatment. All healthcare interventions should have the long-term interest of patients as the focus point (Doyle 2008).
To date, there has been little policy recognition of the concept of survivorship or how best to support patients beyond the acute phase of treatment. The Cancer Reform Strategy (DH 2007) is the first policy setting out a commitment to improve patients’ experience of living with and beyond cancer. From this report, the National Cancer Survivorship Initiative (NCSI) was established. The NCSI vision (DH et al 2010) sets out to determine the possible approaches to survivorship care and how these can best be tailored to meet individual patients’ needs. This work focuses on creating long-term holistic assessment and care planning, ensuring that post-treatment care is practical and sustained. A single record of treatment is proposed, written intelligibly for patients outlining the basis of conversations about their care and a summary of the type of cancer; what procedure/treatment they had received; what to expect immediately post-treatment; what the consequences of treatment might be in the medium to long term; what patients can do optimise their recuperation and recovery; how long side effects and symptoms may last; what signs and symptoms of recurrence to watch for; and how they would be followed up.
There remain significant discrepancies between the ideas of patients, GPs and oncologists of which healthcare professional should follow patients up. Some patients desire follow-up care with their consultant (Cheung et al 2009). However, many patients are not seen by the consultant in follow-up care. Other patients prefer to be followed up by their GP as they know their case more thoroughly than anyone and the patient has easier access to them. However, patients perceive that the GP may not actually possess the in-depth specialist knowledge and skill to provide care. A GP ‘review and recall system’ is also proposed, ensuring appropriate, patient-specific, primary care for cancer survivors. GPs perceive themselves to have a central role in follow up, disease surveillance and screening for other cancers (Cheung et al 2009).
Alberts W.M. Follow up and surveillance of the patient with lung cancer: what do you do after surgery? Respirology. 2007;12:16–21.
Badr H., Carmack Taylor C.L. Social constraints and spousal communication in lung cancer. Psychooncology. 2006;15:673–683.
Brant J.M., Beck S., Dudley W.N., et al. Symptom trajectories in post treatment cancer survivors. Cancer Nursing. 2011;34(1):67–77.
Cheung W.Y., Neville B.A., Cameron D.B., et al. Comparison of patient and physician experience for cancer survivorship care. Journal of Clinical Oncology. 2009;27:1.
Cooley M.E. Symptoms in adults with lung cancer: a systemic research review. J. Pain. Symptom. Manage.. 2000;19(2):137–153.
Cox K., Wilson E. Follow-up for people with cancer: nurse led services and telephone interventions. Journal of Advanced Nursing. 2003;43(1):51–61.
Dennison S., Shute T. Identifying patients concerns: improving the quality of patient visits to the oncology out-patient department – a pilot study. European Journal of Oncology Nursing. 2000;4:91–98.
Department of Health. A policy framework for commissioning cancer services. London: Calman-Hine report). HMSO; 1995.
Department of Health. A first class service: quality in the new NHS. London: HMSO; 1998.
Department of Health. The NHS cancer plan. London: HMSO; 2000.
Department of Health. The NHS cancer plan and the new NHS. London: HMSO; 2004.
Department of Health. The cancer reform strategy. London: HMSO; 2007.
Department of Health, Macmillan Cancer Support and NHS Improvements. National Cancer Survivorship Initiative: vision. London: HMSO; 2010.
Doyle N. Cancer survivorship: evolutionary concept analysis. Journal of Advanced Nursing. 2008;62(4):499–509.
Johansson S., Steinbeck G., Hursti T., et al. Aspects of patient care. Interviews with relapse free testicular patients in Stockholm. Cancer Nursing. 1992;15:54–60.
Karmaker M.K., Ho A.M. Post thoracotomy pain syndrome. Thoracic Surgery Clinics. 2004;14:345–352.
Krishnasamy M., Wilkie E., Haviland J. Lung cancer health care needs assessment: patients’ and informal carers’ responses to a national mail questionnaire survey. Palliative Medicine. 2001;15:213–227.
Llewellyn C.D., Weinman J., McGurk M., Humphris G. Can we predict which head and neck survivors develop a fear of recurrence? Journal of Psychosomatic Research. 2008;65:525–532.
Macmillan Cancer Support. Two million reasons: the cancer survivorship agenda. London: Macmillan Cancer Support; 2008.
Macmillan Cancer Support. Health and wellbeing survey. London: Macmillan Cancer Support; 2008.
Maliski S.L., Sarna L., Evangelista L., Padilla G. The aftermath of lung cancer. Cancer Nursing. 2003;26(3):237–244.
Moore A. Health and wellbeing clinics. A way out of limbo. The Health Service Journal Supplement. 2011;120(6199):S4–S5.
Mullan F. Seasons of survival: reflections of a physician with cancer. New England Journal of Medicine. 1985;313:270–273.
National Coalition for Cancer Survivorship. Our history. Online. Available at: http://www.canceradvocacy.org/about-us/our-history.html, 1986. (accessed November 2011)
Office for National Statistics. Mortality statistics: cause, 2005. London: ONS; 2007.
Office for National Statistics. Cancer statistics registrations. England, Series MB1, No. 37. Online. Available at:. 2008. http://www.ons.gov.uk/ons/publications/index.html
RDSi research commissioned by Macmillan Cancer Relief. UK patient survey. 2006. (Unpublished)
Ronson A., Body J.J. Psychosocial rehabilitation of cancer patients after curative therapy. Support. Care Cancer. 2002;10:281–291.
Sarna L., McCorkle R. Burden of care and lung cancer. Cancer Practice. 1996;4:245–251.
Sarna L., Evangelista L., Tashkin D., et al. Impact of respiratory symptoms and pulmonary function on quality of life of long term survivors of non-small cell lung cancer. Chest. 2004;125:439–445.
Simm C., Aston J., Williams C., et al. Organisations’ responses to the Disability Discrimination Act. Report 410. London:Department for Work and Pensions; 2007.
Sugimura H., Yang P. Long-term survivorship in lung cancer – a review. Chest. 2006;129:1088–1097.
Torjesen I. A new approach to aftercare. The Health Service Journal Supplement. 2010;120(6199):S2–S3.
Wyatt G., Kurtz M.E., Liken M. Breast cancer survivors: an exploration of quality of life issues. Cancer Nursing. 1993;16(6):440–448.
Cooley C. Cancer survivorship, part 1: how services need to change for those living with and beyond cancer. Nursing Times. 2010;106(20):24–25.
Cooley C. Cancer survivorship, part 2: providing advice and support to those living with and beyond cancer. Nurs. Times. 2010;106(21):17–18.
Davies N.J. Cancer survivorship: living with or beyond cancer. Cancer Nursing Practice. 2009;8(7):29.
Ganz P.A. The 3 ‘Ps’ of cancer survivorship. BMC Med.. 2011;9(14):1–3.
McBride S., Whyte F. Survivorship and the cancer follow up clinic. European Journal of Cancer Care (Engl.). 1998;7:47–55.
National Cancer Survivorship Initiative, http://www.ncsi.org.uk/.
US National Coalition for Cancer Survivorship, http://www.canceradvocacy.org/.
World Cancer Research Fund (recommendations for cancer survivors to prevent cancer), http://www.wcrf-uk.org/cancer_prevention/recommendations/prevention_for_survivors.php.